John E. Le Lay

John E. Le Lay

Auto-generated profile, based on publicly available information

John E. Le Lay

Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JLJohn E. Le Lay
John E. Le Lay
QDQun Du
Qun Du
MMMinal B. Mehta
Minal B. Mehta
NBNicholas Bhagroo
Nicholas Bhagroo
BHB. Timothy Hummer
B. Timothy Hummer
JGJoseph S Grimsby
Joseph S Grimsby
Neutralization of endothelial lipase with a monoclonal antibody raises functional HDL in both nonhuman primates and in healthy humans.